UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2024 - Earnings Conference Call March 10, 2025 10:00 AM ET Company Participants Vincent Perrone - Head of IR Liz Barrett - President and CEO Mark Schoenberg - CMO David Lin - CCO Chris Degnan - CFO Conference Call Participants Michael Schmidt - Guggenheim Raghuram Selvaraju - H. C. Wainwright Leland Gershel - Oppenheimer Paul Choi - Goldman Sachs Aydin Huseynov - Ladenburg Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the UroGen Ph ...